Conference abstract · 7 Nov 2016
PerspectivePublished 29 Oct 2025
Advancing Targeted, Disease-Modifying Brain Therapies
Subjects
ChemistryPharmaceutical SciencesSimilar by topic
Conference abstract · 22 Aug 2016
Limited value of relative risk reductions for assessing the benefits of disease-modifying therapies for multiple sclerosis
Conference abstract · 29 Aug 2018
Development of FAF1 inhibitor KM-819 as a disease-modifying drug for treatment of Parkinson’s disease
Conference abstract · 29 Aug 2018
Development of FAF1 inhibitor KM-819 as a disease-modifying drug for treatment of Parkinson’s disease
Conference abstract · 25 Sep 2017
Novel disease-modifying drugs inhibiting alpha-synuclein aggregation in Parkinson’s disease model mice
More from this journal
The newest in Medicinal Chemistry.
Brief report · 30 Jun 2026
Covalent Drugs in Medicinal Chemistry: Emerging Opportunities and Ongoing Challenges
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Julia Novak”

